SEARCH WITHIN CONTENT
Citation Information : Polish Journal of Microbiology. Volume 65, Issue 4, Pages 425-432, DOI: https://doi.org/10.5604/17331331.1227668
License : (CC BY-NC-ND 4.0)
Received Date : 23-September-2015 / Accepted: 08-March-2016 / Published Online: 28-December-2016
Cytomegaloviruses are common worldwide, with variable frequency of infections. The infection in pregnancy may lead to pregnancy loss or serious sequelae for the child. To understand the risk posed by CMV in Poland we conducted cross-sectional study on women aged 15–49 basing on existing serum bank. Age dependent CMV incidence, the rates of congenital infection and sequelae were modelled from sero-prevalence, literature and demographic data. The overall anti-CMV IgG prevalence was 81.9% increasing from 74.3% in < 30 years old to 94.3% in subjects 45+ years old. The lowest incidence was estimated at the age of 15 and the highest at the age 34 (3.8 and 8.95 respectively/100 women/year). The estimated rate of cCMV varies from 22.4 to 37.2 per 1000 live birth depending on the assumptions made. The proportion of cases due to secondary infection ranged from 34.8% to 49.9% accordingly.
Adler S.P., J.W. Finney, A.M. Manganello and A.M. Best. 2004. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J. Pediatr. 145: 485–491.
Boppana S.B., L.B. Rivera, K.B. Fowler, M. Mach and W.J. Britt. 2001. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 344: 1366–1371.
Cannon M.J., T.B. Hyde and D.S. Schmid. 2011. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev. Med. Virol. 21: 240–255.
Central Statistical Office of Poland (CSOP). 2014. http://stat.gov.pl/en/, 2014.05.14.
Cordier A.G., S. Guitton, C. Vauloup-Fellous, L. Grangeot-Keros, A. Benachi and O. Picone. 2012a. Awareness and knowledge of congenital cytomegalovirus infection among health care providers in France. J. Clin. Virol. 55: 158–163.
Cordier A.G., S. Guitton, C. Vauloup-Fellous, L. Grangeot-Keros, J.M. Ayoubi, A. Benachi and O. Picone. 2012b. Awareness of cytomegalovirus infection among pregnant women in France. J. Clin. Virol. 53: 332–337.
Dahle A.J., K.B. Fowler, J.D. Wright, S.B. Boppana, W.J. Britt and R.F. Pass. 2000. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J. Am. Acad. Audiol. 11: 283–290.
Davidson A.C. and D.V. Hinkley. 1997. Bootstrap methods and their application. 1st ed. University Press, Cambridge.
de Ory F., R. Ramírez, L. García Comas, P. León, M.J. Sagües and J.C. Sanz. 2004. Is there a change in cytomegalovirus seroepidemiology in Spain? Eur. J. Epidemiol. 19: 85–89.
de Vries J.J., E.W. van Zwet, F.W. Dekker, A.C. Kroes, P.H. Verkerk and A.C. Vossenet. 2013. The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model. Rev. Med. Virol. 23: 241–249.
Dollard S.C., S.D. Grosse and D.S. Ross. 2007. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 17: 355–363.
Enders G., U. Bäder, U. Bartelt and A. Daiminger. 2003. Cytomegalovirus (CMV) prevalence and frequency of CMV primary infections in pregnant women (in German). Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 46: 426–432.
Engman M.L., G. Malm, L. Engstrom, K. Petersson, E. Karltorp, K. Tear Fahnehjelm, I. Uhlen, C. Guthenberg and I. Lewensohn-Fuchs. 2008. Congenital CMV infection: prevalence in newborns and the impact on hearing deficit. Scand. J. Infec. Dis. 40: 935–942.
Fowler K.B., A.J. Dahle, S.B. Boppana and R.F. Pass RF. 1999. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J. Pediatr. 135: 60–64.
Gardella C. 2008. Cytomegalovirus in Pregnancy. In: The Global Library of Women’s Medicine DOI 10.3843/GLOWM.10182.
Godzik P., A. Kołakowska, K. Madaliński, M. Stepień, A. Zieliński, A. Góralewska, M. Kazimierska, R. Kunc-Kozioł, B. Nadolska, A. Pawłowska and others. 2012. Prevalence of anti-HCV antibodies among adults in Poland-results of cross-sectional study in general population (in Polish). Przegl. Epidemiol. 66: 575–580.
Gratacap-Cavallier B., J.L. Bosson, P. Morand, N. Dutertre,B. Chanzy, P.S. Jouk, C. Vandekerckhove, P. Cart-Lamy andJ.M. Seigneurin. 1998. Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur. J. Epidemiol. 14: 147–152.
Hyde T.B., D.S. Schmid and M.J. Cannon. 2010. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev. Med. Virol. 20: 311–326.
Ikuta K., T. Minematsu, N. Inoue, T. Kubo, K. Asano,K. Ishibashi, T. Imamura, H. Nakai, T. Yoshikawa, H. Moriuchi and others. 2013. Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers. J. Clin. Virol. 58: 474–478.
Imbs D. and H. Rudnicka. 1987. Seroepidemiological studies for the detection of cytomegalovirus (CMV) and herpes simplex virus (HSV) infections among girls and women in Poland (in Polish). Przegl. Epidemiol. 41: 286–294.
Kenneson A. and M.J. Cannon. 2007. Review meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 17: 253–276.
Kiss P., D. de Bacquer, L. Sergooris, M. de Meester and M. VanHoorne. 2002. Cytomegalovirus infection: an occupational hazard to kindergarten teachers working with children aged 2.5–6 years. Int. J. Occup. Environ. Health 8: 79–86.
Knowles S.J., K. Grundy, I. Cahill, M.T. Cafferkey amd M. Geary. 2005. Low cytomegalovirus sero-prevalence in Irish pregnant women. Ir. Med. J. 98: 210–212.
Korndewal M.J., L. Mollema, I. Tcherniaeva, F. van der Klis, A.C. Kroes, A.M. Oudesluys-Murphy, A.C. Vossen and H.E. de Melker. 2015. Cytomegalovirus infection in The Netherlands: sero-prevalence, risk factors, and implications. J. Clin. Virol. 63: 53–58.
Liu X., J. Yuan, A.W. Wu, P.W. McGonagill, C.S. Galle andJ.L. Meier. 2010. Phorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells. J. Virol. 84: 8495–8508.
Ludwig A. and H. Hengel. 2009. Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill. 14:26–32.
Manicklal S., V.C. Emery, T. Lazzarotto, S.B. Boppana andR.K. Gupta. 2013. The “silent” global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 26: 86–102.
Mustakangas P., S. Sarna, P. Ammälä, M. Muttilainen, P. Koskela and M. Koskiniemi. 2000. Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study. Int. J. Epidemiol. 29: 587–591.
Nyholm J.L. and M.R. Schleiss. 2010. Prevention of maternal cytomegalovirus infection: current status and future prospects. Int.J. Womens Health 9:23–35.
Price S.M., E. Bonilla, P. Zador, D.M. Levis, C.L. Kilgo andM.J. Cannon. 2014. Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey. BMC Women’s Health 14: 144
Revello M.G., G. Campanini, A. Piralla, M. Furione, E. Percivalle, M. Zavattoni and G. Gerna. 2008. Molecular epidemiology of primary human cytomegalovirus infection in pregnant women and their families. J. Med. Virol. 80: 1415–1425.
Revello M.G., E. Fabbri, M. Furione, M. Zavattoni, D. Lilleri,B. Tassis, A. Quarenghi, C. Cena, A. Arossa, L. Montanari and others. 2011. Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J. Clin. Virol. 50: 303–307.
Shkedy Z., M. Aerts, G. Molenberghs, P. Beutels and P. Van Damme. 2006. Modelling age-dependent force of infection from prevalence data using fractional polynomials. Stat. Med. 25: 1577–1591.
Sinclair J. and P. Sissons. 2006. Latency and reactivation of HCMV. J. Gen. Virol. 87: 1763–1779.
Tookey P.A., A.E. Ades and C.S. Peckham. 1992. Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch. Dis. Child 67: 779–783.
Wang C., X. Zhang, S. Bialek and M.J. Cannon. 2011. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin. Infect. Dis. 52: 1–13.
Yamamoto A.Y., M.M. Mussi-Pinhata, S.B. Boppana, Z. Novak, V.M. Wagatsuma, P.F. Oliveira, G. Duarte and W.J. Britt. 2010. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am. J. Obstet. Gynecol. 202: 297e1–297e8.
Yamamoto A.Y., R.A. Castellucci, D.C. Aragon and M.M. Mussi-Pinhata. 2013. Early high CMV seroprevalence in pregnant women from a population with a high rate of congenital infection. Epidemiol. Infect. 141: 2187–2191.